Tweet
<img alt="" height="1" width="1" />
Lilly, Boehringer collaborate on diabetes drugs
The Associated Press
INDIANAPOLIS (AP) — Eli Lilly and Co. will team with German drugmaker Boehringer Ingelheim to develop diabetes treatments, as the US pharmaceutical company pushes to fill a looming revenue gap created by expiring patents for several key drugs. ...
Lilly CEO: Diabetes Deal To Help Address Patent ChallengesWall Street Journal
Eli Lilly in 5-drug diabetes pact with BoehringerReuters
Lilly, Boehringer collaborate on diabetes drugsWashington Post
Financial Times -Indianapolis Business Journal -PR Newswire (press release)
all 146 news articles »
More...